ArticleInternational journal of epidemiology2026
Contributions of preeclampsia to preterm delivery: a hypothetical interventional cohort study using incremental propensity scores.
Article in International journal of epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundPreeclampsia remains a leading cause of preterm delivery (PTD). Conventional average causal effect estimands may not always be perfectly suited for assessing preeclampsia's contributions because they rely on uniform counterfactual scenarios, such as everyone suffering from preeclampsia. A complementary approach is the incremental propensity score intervention (IPSI), which can address a more action-oriented causal inquiry: How would the population average risk of PTD change from current observed levels if each individual's odds of preeclampsia were reduced by a given amount?
methodsWe applied IPSI to two US population cohorts of singleton pregnancies, separated by two decades (1998-2002, 16.7 million; 2020-2023, 14.2 million), to evaluate the causal effects of gestational hypertension/preeclampsia (GHTN/PE) on PTD within each cohort. We developed and implemented a sensitivity analysis procedure using bias formulas to gauge the impact of potential unmeasured confounding.
resultsBetween 1998 and 2002, halving the individual odds of GHTN/PE would reduce the population average risk of PTD from observed [risk ratio (RR) = 0.969, 95% confidence interval (CI) 0.969-0.970]. Between 2020 and 2023, when GHTN/PE was more prevalent, halving the odds of preeclampsia would lead to an even greater reduction in average PTD risk (RR = 0.948, 95% CI 0.947-0.948). Sensitivity analyses demonstrated that these conclusions held under assumptions encoding relatively strong unmeasured confounding.
conclusionsThe IPSI approach offers more nuanced understanding and clinically meaningful interpretations of causal effects, such as by how much partially reducing the odds of GHTN/PE, while allowing it to remain non-zero, can lower the average risk of PTD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.